Projected Earnings Date: 2023-11-06    (Delayed quote data   )
Last
 
Change
 ⇓ 0.00   (%)
Volume
  0
Open
 
High
 
Low
 
8EMA (Daily)
 0.00
40EMA (Daily)
 
50EMA (Daily)
 
STO (Daily)
 
MACD Hist (Daily)
 
8EMA (Weekly)
 113.033
40EMA (Weekly)
 105.23
50EMA (Weekly)
 103.69
STO (Weekly)
 98.810
MACD Hist (Weekly)
 2.304
Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com